Kristin Rocco, NP
Adult Health · Roslyn, NYNPI 1972162071
Payments from drug & device makers
Across 216 payments — averaging $42.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Actelion Pharmaceuticals US, Inc.$794
- AstraZeneca$466
- Alnylam Pharmaceuticals Inc.$416
- Boehringer Ingelheim$316
- Bayer$174
- plus $640 from 14 others
What the payments were for
- Travel & lodging$1,37515%
- Food & beverage$7,66983%
- Education$1702%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 91 | $6,408 |
| Actelion Pharmaceuticals US, Inc. | 28 | $794 |
| AstraZeneca | 23 | $466 |
| Alnylam Pharmaceuticals Inc. | 23 | $416 |
| Boehringer Ingelheim | 14 | $316 |
| Bayer | 8 | $174 |
| Merck | 4 | $88 |
| Scpharmaceuticals Inc. | 3 | $85 |
| United Therapeutics Corporation | 3 | $66 |
| Akcea Therapeutics, Inc. | 3 | $63 |
| Vifor Pharma, Inc. | 3 | $56 |
| Abiomed | 2 | $49 |
| Impulse Dynamics (USA) Inc. | 2 | $46 |
| Novartis | 2 | $45 |
| Kestra Medical Technology Services, Inc. | 2 | $43 |
| Daxor Corporation | 1 | $25 |
| Novo Nordisk | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$3,761
- CARDIOMEMS$548
- QUADRA ASSURA$156
- Durata Defibrillation ICD Lead$155
- UPTRAVI$150
- OPSUMIT$150
How this compares
$9,214 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amiodarone Hcl | 16 | $1,200 |
| Bumetanide | 17 | $1,143 |
| Sildenafil Citrate | 13 | $903 |
| Warfarin Sodium | 36 | $718 |
| Pantoprazole Sodium | 24 | $434 |
| Metoprolol Succinate | 19 | $407 |
| Digoxin | 13 | $352 |
| Famotidine | 18 | $263 |
| Carvedilol | 12 | $260 |
| Atorvastatin Calcium | 14 | $158 |
| Allopurinol | 11 | $131 |
| Spironolactone | 19 | $104 |
Paid to pharmacies, not to this prescriber.
Other adult health in Roslyn
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Katelyn McCormackAmherst$201K
- Mary CiechoskiBuffalo$200K
- Patricia LorussoLancaster$161K
- Jennifer FioriniGlens Falls$151K
- Tia AlbroRochester$142K
- Maria Gigante-BaggettEast Syracuse$92K
- Jane PattersonRochester$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.